News and Updates

Nonprofits are bridging R&D’s valley of death

How charitable firms such as Advancium are helping to right the market wrongs of drug development.

Deerfield Management Announces Third Annual XSeed Award to Support Underfunded and Underrepresented NYC Life Science Startups

• Two life science startup companies to each be awarded up to $250,000 in grants • Winners will receive access to the Cure® ecosystem at 345 Park Avenue South in New York City

Deerfield Management and BioSymetrics partner to discover and develop novel therapeutics

Collaboration to advance cardiology and neurology targets using phenomics and genomic data to improve human health

Moffitt Cancer Center and Deerfield Management Launch Bayfield Therapeutics

Deerfield commits up to $130 million over 10 years to accelerate Moffitt’s innovative drug discovery research

BIDMC and Deerfield Management announce research collaboration to accelerate the creation and development of therapeutics

Deerfield Management commits up to $130 million to translate BIDMC research programs from the bench to the bedside

NYC Healthcare Innovation Campus, Cure®, Fuels Economic Growth

• 17 companies across the healthcare industry join Cure’s ecosystem • More than $550 million raised by residents since 2021 • Cure hosts 40 industry events engaging 2,000 healthcare leaders to date

Leaders Magazine: Advancing healthcare - an interview with James Flynn, Managing Partner, Deerfield

Illumina and Deerfield Management partner to accelerate drug development

First-of-its-kind partnership will identify drug targets and accelerate novel therapy development using genomics and artificial intelligence

PE Hub: Every disease is a finite puzzle

Deerfield Management Announces XSeed Award Winners

Break Into the Boardroom Fills Over 50 Healthcare Board Seats With Women Leaders

New Independent Charitable Health Care Organization Advancium Health Network Launches